Skip to main content
. 2021 Aug 23;10:303. Originally published 2021 Apr 19. [Version 3] doi: 10.12688/f1000research.52086.3

Table 2. Comparison of anti-vinculin and anti-CdtB in patients with IBS versus control subjects.

Parameter Patients with IBS
(Mean ± SD)
Control Subjects
(Mean ± SD)
P
Anti-vinculin 1.58 ± 0.496 1.13 ± 0.249 0.001
Anti-CdtB 2.47 ± 0.60 2.1 ± 0.24 0.001